Michał Maźniak

Dr. Michał Maźniak


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2024 in Cancers
Verified
Journal Article
Open access
PDF file
PJPatryk Jasielski
Patryk Jasielski
IZIzabela Zawlik
Izabela Zawlik
ABAnna Bogaczyk
Anna Bogaczyk
NPNatalia Potocka
Natalia Potocka
SPSylwia Paszek
Sylwia Paszek
TKTomasz Kluz
Tomasz Kluz
Endometrial cancer is one of the most common malignant tumours in women. The development of this tumour is associated with several genetic disorders, many of which are still unknown. One type of RNA molecules currently being intensively studied in many types of cancer are long non-coding RNAs (lncRNAs). LncRNA-coding genes occupy a large fraction of the human genome. LncRNAs regulate many aspects of cell development, metabolism, and other physiological processes. Diverse types of lncRNA can function as a tumour suppressor or an oncogene that can alter migration, invasion, cell proliferation, apoptosis, and immune system response. Recent studies suggest that selected lncRNAs are important in an endometrial cancer course. Our article describes over 70 lncRNAs involved in the development of endometrial cancer, which were studied via in vivo and in vitro research. It was proved that lncRNAs could both promote and inhibit the development of endometrial cancer. In the future, lncRNAs may become an important therapeutic target. The aim of this study is to review the role of lncRNAs in the development of carcinoma of uterine body.

15 April 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ABAnna Bogaczyk
Anna Bogaczyk
TZTomasz Zuzak
Tomasz Zuzak
PJPatryk Jasielski
Patryk Jasielski
MMMichał Maźniak
Michał Maźniak
AWAndrzej Wróbel
Andrzej Wróbel
TKTomasz Kluz
Tomasz Kluz
Background: Endometrial cancer is one of the most common cancers in women. In recent years, minimally invasive methods such as laparoscopy and robotic surgery have become very popular. Robotic surgery is a rapidly evolving and continuously improving modality. Methods: The main goal of our study was to compare patients operated on with the da Vinci robot with laparoscopy. The study included 300 patients with endometrial cancer who underwent surgery using the da Vinci robotic system and 80 patients with endometrial cancer who underwent laparoscopic surgery. Results: We have demonstrated that robot-assisted surgery is associated with significantly lower blood loss and a reduced risk of complications, whereas operative time remains shorter with laparoscopy. At the same time, we have observed that prolonged robotic operative time occurs particularly in older patients and those with a higher BMI, which should be taken into account when planning surgical procedures. Conclusions: Further research is needed to better define the groups of patients who benefit most and to optimize surgical strategies.